 Paul MacLean
Concepts (555)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 54 | 2023 | 2505 | 5.680 |
Why?
| | Weight Gain | 26 | 2023 | 453 | 5.070 |
Why?
| | Weight Loss | 24 | 2022 | 642 | 4.520 |
Why?
| | Energy Metabolism | 31 | 2021 | 727 | 4.430 |
Why?
| | Physical Conditioning, Animal | 9 | 2020 | 194 | 2.580 |
Why?
| | Energy Intake | 17 | 2022 | 427 | 2.300 |
Why?
| | Dietary Fats | 14 | 2019 | 287 | 1.960 |
Why?
| | Caloric Restriction | 7 | 2022 | 89 | 1.650 |
Why?
| | Lactation | 8 | 2020 | 149 | 1.600 |
Why?
| | Rats, Wistar | 18 | 2021 | 368 | 1.600 |
Why?
| | Adipose Tissue | 15 | 2022 | 545 | 1.590 |
Why?
| | Body Weight | 15 | 2020 | 868 | 1.450 |
Why?
| | Diet, High-Fat | 15 | 2023 | 225 | 1.450 |
Why?
| | Milk, Human | 6 | 2022 | 127 | 1.430 |
Why?
| | Muscle, Skeletal | 19 | 2022 | 1468 | 1.240 |
Why?
| | Appetite | 2 | 2020 | 52 | 1.230 |
Why?
| | Body Composition | 11 | 2021 | 590 | 1.150 |
Why?
| | Rats | 32 | 2022 | 4913 | 1.150 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 45 | 1.100 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 73 | 1.100 |
Why?
| | Lipid Metabolism | 9 | 2017 | 441 | 1.060 |
Why?
| | Animals | 71 | 2023 | 31565 | 1.060 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 122 | 1.030 |
Why?
| | Motor Activity | 3 | 2019 | 635 | 1.020 |
Why?
| | Adipocytes | 6 | 2022 | 188 | 1.000 |
Why?
| | Ovariectomy | 9 | 2022 | 116 | 0.950 |
Why?
| | Appetite Regulation | 2 | 2017 | 26 | 0.930 |
Why?
| | Ovary | 3 | 2017 | 190 | 0.930 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 484 | 0.910 |
Why?
| | Biomedical Research | 3 | 2023 | 582 | 0.900 |
Why?
| | Cholesterol | 5 | 2019 | 368 | 0.850 |
Why?
| | Breast Feeding | 5 | 2022 | 366 | 0.820 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 286 | 0.820 |
Why?
| | Estrogens | 3 | 2018 | 312 | 0.810 |
Why?
| | Awards and Prizes | 1 | 2023 | 56 | 0.810 |
Why?
| | Vasopressins | 3 | 2021 | 56 | 0.810 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 54 | 0.800 |
Why?
| | Eating | 5 | 2022 | 344 | 0.800 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 15 | 0.800 |
Why?
| | Lipogenesis | 3 | 2019 | 56 | 0.790 |
Why?
| | Insulin | 19 | 2022 | 2080 | 0.780 |
Why?
| | Liver | 10 | 2021 | 1633 | 0.770 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 117 | 0.770 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 64 | 0.760 |
Why?
| | Glycoproteins | 5 | 2005 | 304 | 0.750 |
Why?
| | Exercise | 10 | 2019 | 1642 | 0.750 |
Why?
| | Receptor, Insulin | 3 | 2015 | 93 | 0.730 |
Why?
| | Oxygen Consumption | 5 | 2019 | 587 | 0.700 |
Why?
| | Cold Temperature | 2 | 2019 | 125 | 0.680 |
Why?
| | Female | 59 | 2023 | 59324 | 0.670 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 453 | 0.670 |
Why?
| | Thermogenesis | 2 | 2019 | 37 | 0.670 |
Why?
| | Milk | 5 | 2019 | 123 | 0.670 |
Why?
| | Overweight | 4 | 2022 | 473 | 0.660 |
Why?
| | Physical Exertion | 3 | 2011 | 209 | 0.660 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 185 | 0.650 |
Why?
| | Carrier Proteins | 6 | 2005 | 694 | 0.650 |
Why?
| | Sex Characteristics | 3 | 2021 | 636 | 0.640 |
Why?
| | Breast Neoplasms | 6 | 2022 | 1846 | 0.630 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 92 | 0.620 |
Why?
| | Menopause | 2 | 2019 | 271 | 0.610 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 48 | 0.600 |
Why?
| | Mice | 32 | 2022 | 14843 | 0.580 |
Why?
| | Adipogenesis | 1 | 2017 | 42 | 0.570 |
Why?
| | Adiposity | 5 | 2016 | 458 | 0.560 |
Why?
| | Cortical Bone | 1 | 2017 | 18 | 0.560 |
Why?
| | Placenta | 1 | 2023 | 628 | 0.560 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 26 | 0.550 |
Why?
| | Metformin | 2 | 2018 | 274 | 0.550 |
Why?
| | Diet, Reducing | 4 | 2021 | 76 | 0.550 |
Why?
| | Leptin | 6 | 2022 | 210 | 0.550 |
Why?
| | Ibuprofen | 1 | 2017 | 75 | 0.540 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 84 | 0.520 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 4 | 0.520 |
Why?
| | Bone Density | 1 | 2019 | 432 | 0.520 |
Why?
| | Osteogenesis | 2 | 2017 | 181 | 0.510 |
Why?
| | Diet | 9 | 2023 | 1080 | 0.510 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 371 | 0.500 |
Why?
| | Fructose | 5 | 2021 | 100 | 0.500 |
Why?
| | Gene Expression Regulation | 8 | 2021 | 2322 | 0.500 |
Why?
| | Oxytocin | 1 | 2015 | 45 | 0.490 |
Why?
| | Mothers | 4 | 2018 | 650 | 0.490 |
Why?
| | Male | 54 | 2023 | 55396 | 0.490 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 77 | 0.480 |
Why?
| | Therapies, Investigational | 1 | 2014 | 14 | 0.470 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 296 | 0.460 |
Why?
| | Fatty Acids | 8 | 2022 | 380 | 0.450 |
Why?
| | Disease Models, Animal | 10 | 2021 | 3498 | 0.440 |
Why?
| | Transcription Factors | 11 | 2019 | 1526 | 0.440 |
Why?
| | Insulin Resistance | 8 | 2022 | 1072 | 0.440 |
Why?
| | Basal Metabolism | 3 | 2021 | 46 | 0.430 |
Why?
| | Fructokinases | 5 | 2021 | 29 | 0.430 |
Why?
| | Blood Glucose | 10 | 2019 | 1827 | 0.430 |
Why?
| | Pregnancy | 9 | 2023 | 5499 | 0.420 |
Why?
| | Fatty Liver | 5 | 2018 | 209 | 0.420 |
Why?
| | Humans | 61 | 2023 | 114045 | 0.410 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.400 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 63 | 0.400 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 898 | 0.400 |
Why?
| | Fasting | 5 | 2022 | 242 | 0.400 |
Why?
| | Recurrence | 4 | 2019 | 925 | 0.390 |
Why?
| | Monosaccharide Transport Proteins | 2 | 2002 | 45 | 0.380 |
Why?
| | Estrous Cycle | 1 | 2010 | 14 | 0.360 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 319 | 0.360 |
Why?
| | Homeostasis | 7 | 2015 | 570 | 0.360 |
Why?
| | Lipoproteins | 3 | 2000 | 159 | 0.350 |
Why?
| | RNA, Messenger | 9 | 2019 | 2550 | 0.350 |
Why?
| | Body Mass Index | 10 | 2021 | 1957 | 0.350 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 33 | 0.340 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 121 | 0.340 |
Why?
| | Gastrointestinal Microbiome | 3 | 2023 | 502 | 0.340 |
Why?
| | Glucose | 10 | 2023 | 899 | 0.340 |
Why?
| | Vitamin D | 1 | 2013 | 340 | 0.340 |
Why?
| | Calorimetry, Indirect | 5 | 2021 | 69 | 0.320 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 105 | 0.320 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 23 | 0.320 |
Why?
| | Behavior Therapy | 2 | 2021 | 225 | 0.320 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 138 | 0.310 |
Why?
| | Time Factors | 10 | 2019 | 6077 | 0.310 |
Why?
| | Neurons | 1 | 2015 | 1277 | 0.290 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 19 | 0.290 |
Why?
| | Mice, Inbred C57BL | 15 | 2021 | 4680 | 0.290 |
Why?
| | Promoter Regions, Genetic | 4 | 2017 | 1131 | 0.280 |
Why?
| | Mice, Knockout | 12 | 2021 | 2562 | 0.280 |
Why?
| | Adult | 28 | 2023 | 30375 | 0.280 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 1875 | 0.280 |
Why?
| | Triglycerides | 8 | 2019 | 467 | 0.280 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 175 | 0.270 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 60 | 0.270 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2087 | 0.270 |
Why?
| | Adenocarcinoma | 1 | 2012 | 787 | 0.270 |
Why?
| | Lymphoma | 1 | 2007 | 176 | 0.260 |
Why?
| | Dehydration | 2 | 2016 | 40 | 0.260 |
Why?
| | Signal Transduction | 6 | 2022 | 4501 | 0.260 |
Why?
| | Multiple Myeloma | 1 | 2007 | 98 | 0.260 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 141 | 0.250 |
Why?
| | Epithelium | 2 | 2019 | 295 | 0.250 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 320 | 0.250 |
Why?
| | Leukemia | 1 | 2007 | 208 | 0.240 |
Why?
| | Photoperiod | 2 | 2019 | 48 | 0.240 |
Why?
| | Feeding Behavior | 4 | 2018 | 572 | 0.230 |
Why?
| | Hospitalization | 1 | 2013 | 1762 | 0.230 |
Why?
| | DNA-Binding Proteins | 6 | 2019 | 1311 | 0.230 |
Why?
| | Resistance Training | 3 | 2017 | 113 | 0.230 |
Why?
| | Physical Fitness | 2 | 2016 | 180 | 0.230 |
Why?
| | Animals, Newborn | 3 | 2017 | 777 | 0.230 |
Why?
| | Adiponectin | 4 | 2022 | 213 | 0.220 |
Why?
| | Feces | 3 | 2021 | 372 | 0.220 |
Why?
| | Fetal Development | 2 | 2023 | 248 | 0.220 |
Why?
| | Cell Proliferation | 3 | 2017 | 2173 | 0.220 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 270 | 0.220 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 17 | 0.220 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 388 | 0.210 |
Why?
| | Arteriosclerosis | 1 | 2003 | 82 | 0.210 |
Why?
| | Financing, Organized | 1 | 2023 | 33 | 0.210 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 917 | 0.210 |
Why?
| | Exercise Tolerance | 3 | 2016 | 212 | 0.210 |
Why?
| | Parturition | 1 | 2023 | 54 | 0.200 |
Why?
| | Muscle Proteins | 3 | 2012 | 210 | 0.200 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1145 | 0.200 |
Why?
| | Faculty | 1 | 2023 | 126 | 0.200 |
Why?
| | Postmenopause | 4 | 2022 | 301 | 0.200 |
Why?
| | Tamoxifen | 3 | 2021 | 190 | 0.200 |
Why?
| | Disease Progression | 4 | 2018 | 2371 | 0.190 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 43 | 0.190 |
Why?
| | Child Development | 2 | 2018 | 384 | 0.190 |
Why?
| | Mentors | 1 | 2023 | 155 | 0.190 |
Why?
| | Malus | 1 | 2021 | 10 | 0.190 |
Why?
| | Middle Aged | 20 | 2023 | 26605 | 0.180 |
Why?
| | Polyphenols | 1 | 2021 | 16 | 0.180 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 18 | 0.180 |
Why?
| | Thinness | 3 | 2021 | 87 | 0.180 |
Why?
| | Hygromycin B | 1 | 2000 | 1 | 0.180 |
Why?
| | Liver X Receptors | 2 | 2019 | 30 | 0.180 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 138 | 0.180 |
Why?
| | Cinnamates | 1 | 2000 | 10 | 0.180 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1310 | 0.180 |
Why?
| | Sheep | 1 | 2023 | 761 | 0.180 |
Why?
| | Hyperinsulinism | 1 | 2001 | 103 | 0.170 |
Why?
| | Fruit | 1 | 2021 | 119 | 0.170 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 3 | 0.170 |
Why?
| | Animal Feed | 2 | 2019 | 49 | 0.170 |
Why?
| | Kynurenic Acid | 1 | 2020 | 11 | 0.170 |
Why?
| | Transcriptional Activation | 1 | 2002 | 337 | 0.170 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 359 | 0.170 |
Why?
| | Random Allocation | 2 | 2019 | 328 | 0.170 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 94 | 0.170 |
Why?
| | Membrane Proteins | 3 | 2015 | 1016 | 0.170 |
Why?
| | Starch | 1 | 2019 | 20 | 0.170 |
Why?
| | Nutritive Value | 1 | 2019 | 30 | 0.170 |
Why?
| | Cattle | 2 | 2019 | 918 | 0.160 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 15 | 0.160 |
Why?
| | Weaning | 1 | 2019 | 48 | 0.160 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 27 | 0.160 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 92 | 0.160 |
Why?
| | Metabolic Diseases | 2 | 2018 | 98 | 0.160 |
Why?
| | Analysis of Variance | 4 | 2016 | 1218 | 0.160 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 428 | 0.160 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 160 | 0.160 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 470 | 0.160 |
Why?
| | Rats, Sprague-Dawley | 7 | 2015 | 2182 | 0.150 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 36 | 0.150 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 171 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 489 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 43 | 0.150 |
Why?
| | Aromatase | 1 | 2018 | 30 | 0.150 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 28 | 0.150 |
Why?
| | Postpartum Period | 2 | 2020 | 275 | 0.150 |
Why?
| | Rest | 1 | 2018 | 103 | 0.150 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.150 |
Why?
| | Models, Animal | 1 | 2019 | 340 | 0.150 |
Why?
| | Glycogen | 6 | 2010 | 51 | 0.150 |
Why?
| | Mice, Transgenic | 6 | 2017 | 1947 | 0.150 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 30 | 0.150 |
Why?
| | Diglycerides | 1 | 2018 | 53 | 0.150 |
Why?
| | Ghrelin | 2 | 2018 | 33 | 0.150 |
Why?
| | Cell Size | 1 | 2017 | 79 | 0.150 |
Why?
| | Reperfusion Injury | 1 | 2020 | 252 | 0.140 |
Why?
| | Sucrose | 2 | 2018 | 92 | 0.140 |
Why?
| | Sphingolipids | 1 | 2018 | 57 | 0.140 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 60 | 0.140 |
Why?
| | Gastrulation | 1 | 2017 | 8 | 0.140 |
Why?
| | Germ Layers | 1 | 2017 | 7 | 0.140 |
Why?
| | Running | 1 | 2019 | 207 | 0.140 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.140 |
Why?
| | Glaucoma | 1 | 2020 | 201 | 0.140 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 183 | 0.140 |
Why?
| | Neural Pathways | 2 | 2011 | 260 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2000 | 197 | 0.140 |
Why?
| | Chromatography, Gas | 1 | 2016 | 27 | 0.140 |
Why?
| | Computational Biology | 1 | 2020 | 528 | 0.140 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 15 | 0.140 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 60 | 0.140 |
Why?
| | Dyslipidemias | 1 | 2018 | 153 | 0.140 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 84 | 0.140 |
Why?
| | Fibroblasts | 2 | 2017 | 834 | 0.140 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 281 | 0.130 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.130 |
Why?
| | Receptors, Androgen | 1 | 2017 | 131 | 0.130 |
Why?
| | Microbiota | 1 | 2023 | 648 | 0.130 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.130 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 54 | 0.130 |
Why?
| | Pediatric Obesity | 1 | 2022 | 489 | 0.130 |
Why?
| | Glucokinase | 1 | 2015 | 13 | 0.130 |
Why?
| | Hypothalamus | 1 | 2016 | 147 | 0.130 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 14 | 0.130 |
Why?
| | Down-Regulation | 3 | 2008 | 594 | 0.130 |
Why?
| | Trophoblasts | 1 | 2017 | 165 | 0.120 |
Why?
| | Infant | 5 | 2023 | 7943 | 0.120 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.120 |
Why?
| | Methylnitrosourea | 2 | 2018 | 6 | 0.120 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 307 | 0.120 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 182 | 0.120 |
Why?
| | United States | 3 | 2023 | 12137 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 399 | 0.120 |
Why?
| | Circadian Rhythm | 2 | 2009 | 356 | 0.120 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 465 | 0.120 |
Why?
| | Caffeine | 1 | 1995 | 56 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 244 | 0.120 |
Why?
| | Mitochondria | 3 | 2022 | 744 | 0.120 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1003 | 0.120 |
Why?
| | Bariatric Surgery | 1 | 2017 | 160 | 0.120 |
Why?
| | Research Report | 1 | 2014 | 75 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 34 | 0.110 |
Why?
| | Birth Weight | 1 | 2016 | 439 | 0.110 |
Why?
| | Acinar Cells | 1 | 2013 | 12 | 0.110 |
Why?
| | DNA Methylation | 1 | 2017 | 493 | 0.110 |
Why?
| | Pantothenic Acid | 1 | 2013 | 5 | 0.110 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 67 | 0.110 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 532 | 0.110 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1624 | 0.110 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 27 | 0.110 |
Why?
| | Vitamin A | 1 | 2013 | 52 | 0.110 |
Why?
| | Extracellular Space | 1 | 2013 | 116 | 0.100 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 154 | 0.100 |
Why?
| | Integrases | 1 | 2013 | 116 | 0.100 |
Why?
| | Histones | 1 | 2017 | 529 | 0.100 |
Why?
| | Epithelial Cells | 2 | 2020 | 946 | 0.100 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| | Biomarkers | 6 | 2019 | 3397 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 743 | 0.100 |
Why?
| | Cell Separation | 1 | 2013 | 290 | 0.100 |
Why?
| | Research Design | 1 | 2018 | 919 | 0.100 |
Why?
| | Up-Regulation | 2 | 2013 | 802 | 0.100 |
Why?
| | Cytoskeleton | 1 | 2013 | 176 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 801 | 0.100 |
Why?
| | Hormones | 2 | 2010 | 132 | 0.100 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 1726 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2018 | 5038 | 0.100 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 38 | 0.090 |
Why?
| | Glycolysis | 1 | 2012 | 224 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 159 | 0.090 |
Why?
| | Colon | 1 | 2013 | 232 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 293 | 0.090 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 158 | 0.090 |
Why?
| | Colorado | 2 | 2019 | 4090 | 0.090 |
Why?
| | Patient Compliance | 1 | 2014 | 524 | 0.090 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 372 | 0.090 |
Why?
| | Hypertension | 1 | 2018 | 1052 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 328 | 0.090 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 21 | 0.090 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 213 | 0.090 |
Why?
| | Metalloproteases | 1 | 2010 | 37 | 0.090 |
Why?
| | Bone and Bones | 1 | 2012 | 277 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 241 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 36 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 27 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 541 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2017 | 1011 | 0.080 |
Why?
| | Fats | 1 | 2009 | 10 | 0.080 |
Why?
| | Self Report | 1 | 2013 | 695 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 184 | 0.080 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 284 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 181 | 0.080 |
Why?
| | Health Behavior | 1 | 2014 | 701 | 0.080 |
Why?
| | Interleukin-4 | 1 | 2009 | 204 | 0.080 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 139 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2090 | 0.080 |
Why?
| | Cross-Over Studies | 2 | 2021 | 439 | 0.080 |
Why?
| | Risk Factors | 3 | 2018 | 8614 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2016 | 9049 | 0.080 |
Why?
| | Disease Susceptibility | 3 | 2016 | 316 | 0.080 |
Why?
| | Interleukin-2 | 1 | 2009 | 413 | 0.080 |
Why?
| | Transcriptome | 1 | 2013 | 723 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1558 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 20 | 0.070 |
Why?
| | Adolescent | 5 | 2021 | 17800 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 163 | 0.070 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 72 | 0.070 |
Why?
| | Patient Selection | 2 | 2009 | 629 | 0.070 |
Why?
| | Antigens, CD34 | 1 | 2007 | 88 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 167 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1518 | 0.070 |
Why?
| | Retrospective Studies | 3 | 2018 | 12521 | 0.070 |
Why?
| | Leukocyte Count | 1 | 2007 | 292 | 0.070 |
Why?
| | Young Adult | 5 | 2021 | 10444 | 0.070 |
Why?
| | Cell Line | 3 | 2019 | 2629 | 0.070 |
Why?
| | Exercise Test | 1 | 2009 | 547 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 170 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2013 | 1696 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1204 | 0.070 |
Why?
| | Interleukin-6 | 2 | 2022 | 673 | 0.070 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 149 | 0.070 |
Why?
| | Lactates | 3 | 1995 | 78 | 0.070 |
Why?
| | Calorimetry | 3 | 2012 | 60 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 48 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 62 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 739 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3003 | 0.060 |
Why?
| | Models, Biological | 2 | 2018 | 1611 | 0.060 |
Why?
| | Macrophages | 1 | 2012 | 1259 | 0.060 |
Why?
| | Pilot Projects | 2 | 2022 | 1360 | 0.060 |
Why?
| | Lipolysis | 1 | 2005 | 39 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 8 | 0.060 |
Why?
| | Proteins | 2 | 2013 | 906 | 0.060 |
Why?
| | Antigens, CD | 1 | 2007 | 440 | 0.060 |
Why?
| | Aged | 5 | 2018 | 18969 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 192 | 0.060 |
Why?
| | Kinetics | 2 | 2012 | 1547 | 0.060 |
Why?
| | Organ Specificity | 1 | 2005 | 266 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 534 | 0.060 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 234 | 0.060 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 4 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 347 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 24 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 224 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 304 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 1791 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 10 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 19 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 16 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 272 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 42 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 103 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 66 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 75 | 0.050 |
Why?
| | Neutrophils | 1 | 2007 | 1089 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 69 | 0.050 |
Why?
| | Rodentia | 1 | 2022 | 43 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 97 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 102 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 51 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 70 | 0.050 |
Why?
| | Glucose Transporter Type 4 | 1 | 2002 | 36 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 40 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 121 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 183 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 53 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 229 | 0.050 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 49 | 0.050 |
Why?
| | Diabetes Complications | 1 | 2003 | 208 | 0.050 |
Why?
| | Tumor Burden | 1 | 2022 | 258 | 0.050 |
Why?
| | Waist Circumference | 1 | 2021 | 122 | 0.050 |
Why?
| | Phospholipids | 1 | 2022 | 194 | 0.050 |
Why?
| | Drinking | 1 | 2021 | 33 | 0.050 |
Why?
| | Hep G2 Cells | 1 | 2021 | 59 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2018 | 6306 | 0.050 |
Why?
| | Intestines | 2 | 2015 | 325 | 0.040 |
Why?
| | Myogenic Regulatory Factors | 1 | 2000 | 49 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 68 | 0.040 |
Why?
| | MEF2 Transcription Factors | 1 | 2000 | 55 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 590 | 0.040 |
Why?
| | Multienzyme Complexes | 1 | 2000 | 64 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 71 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 130 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 89 | 0.040 |
Why?
| | Child | 2 | 2022 | 18401 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 87 | 0.040 |
Why?
| | Lipoproteins, HDL | 1 | 2000 | 76 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 256 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 4402 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 1 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 127 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 4 | 0.040 |
Why?
| | Dairying | 1 | 2019 | 7 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 14 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2022 | 338 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 39 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 40 | 0.040 |
Why?
| | Neoplasms | 1 | 2012 | 2086 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 38 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 87 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 186 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 271 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 191 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 24 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2019 | 121 | 0.040 |
Why?
| | Japan | 1 | 2018 | 85 | 0.040 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 122 | 0.040 |
Why?
| | Transfection | 1 | 2000 | 863 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 29 | 0.040 |
Why?
| | Cytokines | 2 | 2018 | 1824 | 0.040 |
Why?
| | Stromal Cells | 1 | 2018 | 96 | 0.040 |
Why?
| | Erythrocytes | 1 | 2022 | 568 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 474 | 0.040 |
Why?
| | Nuclear Transfer Techniques | 1 | 2017 | 2 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 613 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2000 | 388 | 0.040 |
Why?
| | Breast | 1 | 2018 | 138 | 0.040 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 116 | 0.040 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 28 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1128 | 0.040 |
Why?
| | Blastocyst | 1 | 2017 | 44 | 0.040 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 21 | 0.040 |
Why?
| | Cytosol | 1 | 2018 | 201 | 0.040 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 40 | 0.040 |
Why?
| | Cyclic AMP | 2 | 1995 | 225 | 0.040 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 94 | 0.040 |
Why?
| | Uric Acid | 1 | 2018 | 148 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2018 | 225 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1075 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 43 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 232 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 283 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 815 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 8 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 208 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 71 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 149 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 168 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 177 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 343 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 143 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 92 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 140 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 541 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 163 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 768 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 162 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1068 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 345 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1656 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 36 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 49 | 0.030 |
Why?
| | Lipids | 1 | 1998 | 564 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 301 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 3861 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1089 | 0.030 |
Why?
| | Perfusion | 1 | 1995 | 147 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 787 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1024 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 622 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 2764 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 360 | 0.030 |
Why?
| | Testosterone | 1 | 2017 | 341 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 71 | 0.030 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 23 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 518 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 63 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 77 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 485 | 0.030 |
Why?
| | Muscles | 1 | 1994 | 320 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1706 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 150 | 0.030 |
Why?
| | Intestine, Small | 1 | 2013 | 121 | 0.030 |
Why?
| | Prevalence | 1 | 2018 | 2247 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 108 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1531 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 142 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2384 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 229 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1471 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 742 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 2700 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 35 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 475 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 337 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 386 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 2784 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 84 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 2958 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 17 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 522 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 366 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 847 | 0.020 |
Why?
| | Birds | 1 | 2008 | 71 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 6195 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 208 | 0.020 |
Why?
| | Brain | 1 | 2018 | 2355 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 36 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 16 | 0.020 |
Why?
| | Breeding | 1 | 2006 | 54 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 14 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 31 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 32 | 0.020 |
Why?
| | PPAR alpha | 1 | 2006 | 52 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 32 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 2006 | 93 | 0.020 |
Why?
| | Adenoviridae | 1 | 2006 | 184 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 2006 | 157 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 218 | 0.010 |
Why?
| | Introns | 1 | 2005 | 227 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 62 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2464 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 8 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 29 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 44 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 110 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 121 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 210 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1611 | 0.010 |
Why?
| | RNA | 1 | 2003 | 806 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 725 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 7 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 328 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 6 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 315 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 78 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 2885 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 421 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1143 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|